McPherson G A, Benjamin I S, Habib N A, Bowley N B, Blumgart L H
Br J Surg. 1982 May;69(5):261-4. doi: 10.1002/bjs.1800690511.
This study is a critical prospective assessment of 37 patients with obstructive jaundice, treated by percutaneous transhepatic biliary drainage. The median duration of drainage was 18 days (range 44-55), and during this period clearance of bilirubin and improvement in creatinine clearance were obtained. Only 10 patients gained weight. Three patients required early laparotomy. Thirty-three patients underwent definitive surgery. Of these, 8 died without leaving hospital. The incidence of infection rose during drainage, and infected bile was clinically significant. Two deaths were associated with infection, arising in the drainage system, producing intrahepatic abscesses around the drain track. While the evidence for a staged approach in the severely ill patient with obstructive jaundice is substantial, the procedure of percutaneous transhepatic tubal drainage carries significant hazards, underemphasized in previous reports. Further controlled assessment is required before this technique is accepted as the initial best option for decompression of the obstructed biliary tract.
本研究是对37例梗阻性黄疸患者进行经皮肝穿刺胆道引流治疗的一项关键前瞻性评估。引流的中位持续时间为18天(范围44 - 55天),在此期间胆红素清除以及肌酐清除率得到改善。只有10例患者体重增加。3例患者需要早期剖腹手术。33例患者接受了确定性手术。其中,8例未出院即死亡。引流期间感染发生率上升,感染性胆汁具有临床意义。2例死亡与感染相关,发生在引流系统,在引流通道周围形成肝内脓肿。虽然对于重症梗阻性黄疸患者采用分期治疗方法的证据充分,但经皮肝穿刺置管引流术存在重大风险,以往报告对此强调不足。在该技术被接受为梗阻性胆道减压的首选最佳初始方案之前,还需要进一步的对照评估。